Leiter LA, Bain SC, Bhatt DL, Buse JB, Mazer CD, Pratley RE, Rasmussen S, Ripa MS, Vrazic H, Verma S
Among patients initiating GLP-1RA use during the initial year of follow-up, the HR for thyroid cancer was significantly higher at 1.85 as compared to patients initiating non-GLP-1RA medications
The injections help with inflammation, energy levels and brain fog
Research in cell culture and animal models indicates that rapidly dividing cancer cells have a high requirement for thiamin (94)
Food and Drug Administration approved two new gene therapies to treat SCD, landing Medicaid squarely in the thick of the CGT coverage and access challenges